COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains “off-label”. The COILSEAL, led by Cerrato et al., offers the first multicenter vision on hospital outcomes and mid-term followup of procedures using coils during coronary angioplasty. Data came from 17 high volume centers in Italy and Spain. 

The use of coils in coronary arteries presents two main indications: the first, and most common, is distal coronary perforation management, typically caused by inadvertent wire advancement into small or fragile territories, especially in the context of chronic total occlusions. These distal perforations are not treatable with coated stents and require precise occlusion strategy. The second indication is percutaneous closure of coronary aneurysms or fistulas, where coated stents can be technical or anatomically unfeasible. 

Technically speaking, coronary coiling is performed with micro catheters that allow positioning immediately above the point of extravasation and progressively deploying the coil until flow ceases completely. In the COILSEAL registry, the vast majority of devices were detachable coils (94%), because of their greater control during deployment. Instead, pushable coils were used exclusively in perforations and represented only 6% of cases.

Read also: Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization.

In coronary perforations, the average number of coils used per patient was 1.89 ± 0.87, with mean length 5.95 ± 3.72 cm and mean width 2.51 ± 0.90 mm. This choice of shorter length and smaller caliber responds to the need to occlude distant and frail segments without compromising side branches or inducing thrombotic propagation. 

The registry included 143 patients that needed coil implantation (0.06% of angioplasty procedures). 79% for perforations and 21% for aneurysms or fistulas. The cohort consisted of high risk patients, mean age 71, mostly men (71%) with high prevalence of multivessel disease and chronic occlusions.

The primary outcome was technical success, defined as absence of contrast extravasation at procedure end. Performance was remarkable, 95.7%, with no difference between perforations and aneurysms/fistulas. Procedural success (technical success with no major in-hospital clinical events) was lower for perforations (83.5% vs. 96.6%), which could be expected seeing the potential severity of this complication. Even so, in-hospital mortality was low, and the need for emergency surgery resulted exceptional (1.4%).

Read also: Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

At midterm followup (mean 2.4 years), the incidence of target vessel failure was 11.4%, with no significant differences between groups. There was higher rate of ischemia driven revascularization in cases of aneurysms or fistulas, consistent with the higher biological complexity of these lesions. Cardiac mortality remained low (4.9%) and the incidence of BARC major bleeding did not show significant differences. 

Conclusions

The COILSEAL registry outcomes have allowed us to concluded that the use of coils in the coronary setting is a safe, effective strategy with very high technical success rates, even in highly complex scenarios. Seeing its size and multicenter nature, this registry has contributed with robust scientific evidence to support a technique that, until now, had relied on small series and individual operator experience. 

Original Title: Contemporary Use of Coils During Percutaneous Coronary Intervention: Insights From the Multicenter COILSEAL Registry. 

Reference: Cerrato E, Piedimonte G, Franzino M, Marengo G, Bollati M, Zecchino S, Rutigliano D, Soriano F, Leoncini M, Mangione R, Sagazio E, Maiellaro F, Jeva F, Ussia GP, Scudiero F, Franzè A, Barbero U, Calderone D, Nicolino A, Ugo F, La Manna A, Costa F, Mazzarotto P, Amat-Santos IJ, Varbella F; CardioGroupVIII‐COILSEAL Study Group. Contemporary Use of Coils During Percutaneous Coronary Intervention: Insights From the Multicenter COILSEAL Registry. Catheter Cardiovasc Interv. 2025 Oct 21. doi: 10.1002/ccd.70233. Epub ahead of print. PMID: 41121637.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...